As of Feb 21, 2025, Moderna, Inc. Intrinsic Value is $67.7. This suggests it may be undervalued by 90.7% compared to its current price of around $35.5.

What is Moderna, Inc. DCF (discounted cash flow) valuation?

As of Feb 21, 2025, Moderna, Inc.'s Discounted Cash Flow (DCF) valuation estimates its share price at N/A. This suggests it may be overvalued by N/A to its current price of around $35.5, using a discount rate of 10.8% and terminal growth rate of 3.0%.

Is Moderna, Inc. overvalued or undervalued?

Moderna, Inc. is currently considered undervalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $67.7, compared to a market price of around $35.5. This suggests a potential undervaluation of 90.7%.